LGALS3 and COVID-19: Serum levels of Gal-1 were significantly higher in COVID-19 patients compared to healthy controls (P<0.001); however, no significant difference was seen between severe and non-severe groups (P=0.263). Gal-3 levels were also significantly higher in COVID-19 patients compared with healthy controls (P<0.001). Contrary to Gal-1, the severe group had higher Gal-3 levels compared to non-severe group (P=0.011).